Magnetic resonance-guided laser-induced thermotherapy in patients with oligonodular hepatocellular carcinoma: Long-term results over a 15-year period

Journal of Clinical Gastroenterology

Volumn 46, Issue 9, 2012, Pages 796-801

  Eichler, Katrin ^a   Zangos, Stephan ^a   Gruber Rouh, Tatjana ^a   Vogl, Thomas J ^a   MacK, Martin G ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

ablation; HCC; MR guided laser induced thermotherapy

Indexed keywords

DIPYRONE; FIBRIN GLUE; LOCAL ANESTHETIC AGENT; MEPIVACAINE; MIDAZOLAM; PETHIDINE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; FEMALE; HUMAN; IMAGING SYSTEM; LASER; LASER APPLICATION KIT; LASER THERMOTHERAPY; LIVER CELL CARCINOMA; LOCAL ANESTHESIA; MAJOR CLINICAL STUDY; MALE; NEODYMIUM LASER; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGONODULAR LIVER CELL CARCINOMA; ONLINE MONITORING; PAIN; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TREATMENT DURATION; TUMOR NECROSIS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; LASER THERAPY; LASERS, SOLID-STATE; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84866242108     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3182641806     Document Type: Article

References (36)

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907-1917. (Pubitemid 37518510)
2. Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin Liver Dis. 2005;25:143-154. (Pubitemid 40781067)
3. Bruix J, Boix L, Sala M, et al. Focus on hepatocellular carcinoma. Cancer Cell. 2004;5:215-219. (Pubitemid 38402113)
4. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421-430. (Pubitemid 32844200)
5. Llovet JM, Bustamante J, Castells A, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999;29:62-67. (Pubitemid 29023987)
6. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005;25:181-200. (Pubitemid 40781071)
7. Wayne JD, Lauwers GY, Ikai I, et al. Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg. 2002;235:722-730; discussion 730-721.
8. Zangos S, Eichler K, Balzer JO, et al. Large-sized hepatocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT). Eur Radiol. 2007;17:553-563. (Pubitemid 46140327)
9. Vogl TJ, Gruber T, Balzer JO, et al. Repeated transarterial chemoembolization in the treatment of liver metastases of colorectal cancer: prospective study. Radiology. 2009;250: 281-289.
10. Shi M, Chen JA, Lin XJ, et al. Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China. World J Gastroenterol. 2010; 16:264-269.
11. Dickinson RJ, Hall AS, Hind AJ, et al. Measurement of changes in tissue temperature using MR imaging. J Comput Assist Tomogr. 1986;10:468-472. (Pubitemid 16066481)
12. Eichler K, Mack MG, Straub R, et al. Oligonodular hepatocellular carcinoma (HCC): MR-controlled laser-induced thermotherapy. Radiologe. 2001;41:915-922. (Pubitemid 33009965)
13. Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646-649.
14. Dachman AH, MacEneaney PM, Adedipe A, et al. Tumor size on computed tomography scans: is one measurement enough? Cancer. 2001;91:555-560. (Pubitemid 32105701)
15. Yao FY, Bass NM, Nikolai B, et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl. 2002;8:873-883. (Pubitemid 35154015)
16. Llovet JM, Di Bescegli AM, Bruix J, et al. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst. 2008;100:689-711.
17. Lammer J, Malagari K, Vogl T, et al. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc Intervent Radiol. 2010;33:41-52.
18. Llovet JM, Vilana R, Bru C, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology. 2001;33:1124-1129. (Pubitemid 32378211)
19. Khan KN, Yatsuhashi H. Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients. Alcohol Alcohol. 2000;35:286-295. (Pubitemid 30433702)
20. Koda M, Murawaki Y, Mitsuda A, et al. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer. 2000; 88:529-537. (Pubitemid 30056925)
21. Shiina S, Teratani T, Obi S, et al. Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology. 2002;62(suppl 1):64-68. (Pubitemid 34702022)
22. Chopra S, Dodd GD 3rd, Chintapalli KN, et al. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrastenhanced CT. AJR Am J Roentgenol. 2001;177:381-387. (Pubitemid 32660499)
23. Lencioni R, Cioni D, Crocetti L, et al. Percutaneous ablation of hepatocellular carcinoma: state-of-the-art. Liver Transpl. 2004;10:S91-S97. (Pubitemid 38247742)
24. Lu DS, Yu NC, Raman SS, et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology. 2005;234:954-960. (Pubitemid 40250843)
25. Schaudt A, Kriener S, Schwarz W, et al. Role of transarterial chemoembolization for hepatocellular carcinoma before liver transplantation with special consideration of tumor necrosis. Clin Transplant. 2009;23(suppl 21):61-67.
26. Cheng BQ, Jia CQ, Liu CT, et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA. 2008;299:1669-1677.
27. Lencioni R, Crocetti L, Petruzzi P, et al. Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study. J Hepatol. 2008;49:217-222.
28. Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology. 2005;234:961-967. (Pubitemid 40250844)
29. de Baere T, Risse O, Kuoch V, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol. 2003;181:695-700. (Pubitemid 37021837)
30. Yamashiki N, Kato T, Bejarano PA, et al. Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers. Am J Gastroenterol. 2003;98:2052-2059. (Pubitemid 37185805)
31. Dong B, Liang P, Yu X, et al. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol. 2003;180:1547-1555. (Pubitemid 36687082)
32. Vogl TJ, Weinhold N, Muller P, et al. MR-controlled laserinduced thermotherapy (LITT) of liver metastases: clinical evaluation. Rontgenpraxis. 1996;49:161-168. (Pubitemid 26253730)
33. Ahrar K, Gowda A, Javadi S, et al. Preclinical assessment of a 980-nm diode laser ablation system in a large animal tumor model. J Vasc Interv Radiol. Apr. 2010;21:555-561.
34. Pacella CM, Francica G, Di Lascio FM, et al. Long-term outcome of cirrhotic patients with early hepatocellular carcinoma treated with ultrasound-guided percutaneous laser ablation: a retrospective analysis. J Clin Oncol. 2009;27: 2615-2621.
35. Pacella CM, Bizzarri G, Francica G, et al. Percutaneous laser ablation in the treatment of hepatocellular carcinoma with small tumors: analysis of factors affecting the achievement of tumor necrosis. J Vasc Interv Radiol. 2005;16:1447-1457. (Pubitemid 43017688)
36. Walser EM. Percutaneous laser ablation in the treatment of hepatocellular carcinoma with a tumor size of 4 cm or smaller: analysis of factors affecting the achievement of tumor necrosis. J Vasc Interv Radiol. 2005;16:1427-1429. (Pubitemid 43017685)